LEADER 04060nam 22005415 450 001 9910298434803321 005 20200706225848.0 010 $a981-13-0289-8 010 $a978-981-13-0289-3 024 7 $a10.1007/978-981-13-0289-3 035 $a(CKB)4100000004835975 035 $a(DE-He213)978-981-13-0289-3 035 $a(MiAaPQ)EBC5433816 035 $a(PPN)229492770 035 $a(EXLCZ)994100000004835975 100 $a20180619d2018 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPharmacotherapeutic Potential of Natural Products in Neurological Disorders$b[electronic resource] /$fby Amritpal Singh Saroya, Jaswinder Singh 205 $a1st ed. 2018. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2018. 215 $a1 online resource (XV, 191 p. 233 illus.) 311 $a981-13-0288-X 320 $aIncludes bibliographical references. 327 $a1. Introduction to Herbal Medicine -- 2. Medicinal Herbs Used in Herbal Medicine for Nervous Disorders -- 3. Neuropharmacology of Genus Hypericum, Hypericin and Hyperforin -- 4. Neuropharmacology of Lavender, Rosemary and Salvia -- 5. Neuropharmacology of Passiflora Genus -- 6. Neuropharmacology of Scutellaria baicalensis Georgi -- 7. Piper methysticum G.Forst - A Potent Anti-anxiety Agent -- 8. Neuropharmacology of Melissa officinalis L. -- 9. Neuropharmacology of Chamomiles -- 10. Neuropharmacology of Bacopa monnieri with reference to Bacosides -- 11. Neuropharmacology of Acorus calamus L. -- 12. Neuropharmacology of Celastrus paniculatus Willd -- 13. Phytopharmacology of Indian Nootropic Convolvulus plauricaulis -- 14. Neuropharmacology of Rhodiola rosea L. -- 15. Neuropharmacology of Salvia miltiorrhiza Bunge (Danshen) -- 16. Neuropharmacology of Withania somnifera Dunal -- 17. Neuropharmacology of Nardostachys jatamansi DC -- 18. Neuropharmacology of Nutritional Supplements -- 19. Neuropharmacology of Valeriana Genus -- 20. Neuropharmacology of Curcumin. 330 $aNatural Products have always played a pivotal role as sources for drug lead compounds. This book is aimed at providing inside purview of the scope of natural products (including herbal and marine) in the possible treatment of neurological disorders. The book explains pre-clinical neuropharmacological investigations done on herbs including Bacopa monnieri, Hypericum perforatum, Passiflora incarnata, Scutellaria baicalensis and Piper methysticum. It provides a comprehensive overview of the role of phytoconstituents like huperzine, curcumin, Salvinorin A, bioflavonoids, sulforaphane, tanshinone IIA, tetramethylpyrazine, tetrahydrocannabinol, and cannabidiol in the treatment of neurological disorders. The book provides a modern concept of herbal medications, neuropharmacology of marine bioactive products and Ayurvedic formulations, herbal drugs with abuse potential and neurotoxic mycotoxins. 606 $aNeurosciences 606 $aPharmaceutical technology 606 $aPharmacy 606 $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aDrug Safety and Pharmacovigilance$3https://scigraph.springernature.com/ontologies/product-market-codes/H69010 615 0$aNeurosciences. 615 0$aPharmaceutical technology. 615 0$aPharmacy. 615 14$aNeurosciences. 615 24$aPharmaceutical Sciences/Technology. 615 24$aDrug Safety and Pharmacovigilance. 676 $a612.8 700 $aSaroya$b Amritpal Singh$4aut$4http://id.loc.gov/vocabulary/relators/aut$01058918 702 $aSingh$b Jaswinder$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910298434803321 996 $aPharmacotherapeutic Potential of Natural Products in Neurological Disorders$92503188 997 $aUNINA